Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Japan industry group to examine clinical site cost discrepancies

Japanese industry group JPMA has opted for cloud-based tech to help it understand why the cost of running a trial in the country varies depending on the site involved.

Japanese industry group mulls site costs

AMRI boosts opiate API biz through tech transfer and supply deal with Saneca

AMRI has inked a deal with Slovakia’s Saneca Pharmaceuticals to bolster its opium-derived API portfolio.

Europe bans drugs tested by GVK; FDA monitors but keeps allowing sales

The US FDA has found no systemic issues affecting the safety or efficacy of generics clinically tested at GVK BioSciences, but says it supports Europe’s ban of around 700 products.

Slowly but surely... CROs gradually shifting to paperless trials, says Veeva

Clinical trial operators are slowly converting to electronic Trial Master Files (eTMFs) but almost a third still rely on paper to manage data, according to cloud-based software provider Veeva.

WuXi enters strategic lab testing partnership with HK-based firm

WuXi PharmaTech has signed a strategic partnership deal to provide exclusive laboratory testing services to Hong Kong-headquartered Lee’s Pharmaceutical.

UK clears first use of e-consent tech in clinical trial

A drugmaker trialling an autoimmune disease treatment in the UK has become the first cleared to use electronic informed consent by the National Health Service (NHS).

Hepalink adding biologics CDMO Cytovance in $200m acquisition

API supplier Hepalink will buy Cytovance for $206m (€183m) in a deal the biologics CDMO says will help expedite its expansion plans.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...